272 related articles for article (PubMed ID: 17294353)
1. How to protect from contrast media-induced nephropathy?
Scheller B
Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
[No Abstract] [Full Text] [Related]
2. Protection from contrast-induced nephropathy: is the answer in?
Dean LS
Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
[No Abstract] [Full Text] [Related]
3. In search of an algorithm to prevent acute kidney injury.
Dauerman HL
JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
[No Abstract] [Full Text] [Related]
4. Of hypes and hopes: N-acetylcysteine and cystatin C.
Schultz MJ; Royakkers AA; Bouman CS
AJR Am J Roentgenol; 2008 Mar; 190(3):W224; author reply W225. PubMed ID: 18287418
[No Abstract] [Full Text] [Related]
5. Are we still wondering or wandering in the dark?
Cattano D
Intern Emerg Med; 2011 Dec; 6(6):485-6. PubMed ID: 21416287
[No Abstract] [Full Text] [Related]
6. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned from the PRESERVE trial.
Partovi S; Trischman T; Kang PS
Br J Radiol; 2018 Jul; 91(1087):20180092. PubMed ID: 29770709
[TBL] [Abstract][Full Text] [Related]
9. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
10. [Value of N-acetylcysteine to prevent nephrotoxicity from iodinated contrast agents].
Deray G
J Radiol; 2004 Jun; 85(6 Pt 1):725-7. PubMed ID: 15243372
[TBL] [Abstract][Full Text] [Related]
11. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based practice for the use of N-acetylcysteine.
Marthaler MT; Keresztes PA
Dimens Crit Care Nurs; 2004; 23(6):270-3. PubMed ID: 15586041
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
14. Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury?
Sivalingam SK; Hariharan MV; Braden GL; Freda BJ
Cleve Clin J Med; 2012 Nov; 79(11):746-9. PubMed ID: 23125323
[No Abstract] [Full Text] [Related]
15. Prevention of contrast nephropathy.
Curhan GC
JAMA; 2003 Feb; 289(5):606-8. PubMed ID: 12578494
[No Abstract] [Full Text] [Related]
16. Acetylcysteine and contrast agent-associated nephrotoxicity.
Briguori C; Manganelli F; Scarpato P; Elia PP; Golia B; Riviezzo G; Lepore S; Librera M; Villari B; Colombo A; Ricciardelli B
J Am Coll Cardiol; 2002 Jul; 40(2):298-303. PubMed ID: 12106935
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity of contrast media and protective effects of acetylcysteine.
Briguori C; Quintavalle C; De Micco F; Condorelli G
Arch Toxicol; 2011 Mar; 85(3):165-73. PubMed ID: 21140133
[TBL] [Abstract][Full Text] [Related]
18. Does N-acetylcysteine prevent contrast-induced nephropathy?
Vaitkus PT
Am J Cardiol; 2002 Dec; 90(12):1424; author reply 1424-5. PubMed ID: 12480065
[No Abstract] [Full Text] [Related]
19. Radiocontrast nephropathy: managing the high-risk patient. Introduction.
Lepor NE
Rev Cardiovasc Med; 2001; 2 Suppl 1():S1-3. PubMed ID: 12508796
[No Abstract] [Full Text] [Related]
20. [Contrast media-induced nephropathy: clinical burden and current attempts for prevention].
Habeb M; Ağaç MT; Aliyev F; Pehlivanoğlu S; Ongen Z
Anadolu Kardiyol Derg; 2005 Jun; 5(2):124-9. PubMed ID: 15939688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]